Yamaguchi, Manako
Sekine, Masayuki
Hanley, Sharon J. B.
Kudo, Risa
Hara, Megumi
Adachi, Sosuke
Ueda, Yutaka
Miyagi, Etsuko
Enomoto, Takayuki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP15ck0106103, JP15ck0106103, JP15ck0106103)
Article History
Received: 10 February 2020
Accepted: 5 January 2021
First Online: 3 February 2021
Competing interests
: M. Y. received lecture fees from Merck Sharp and Dohme. T. E. received lecture fees from Merck Sharp and Dohme. Y. U. received lecture fees from GlaxoSmithKline/Japan Vaccine and Merck Sharp and Dohme, as well as research funds from Merck Sharp and Dohme. E. M. received honoraria and lecture fees from Roche Diagnostics and Merck Sharp and Dohme, as well as grants from Merck Sharp and Dohme. M. H. received lecture fees from GlaxoSmithKline/JapanVaccine, Merck Sharp and Dohme, and Sanofi Pasteur Inc. All other authors report no potential conflicts.